MOUNJARO

Active ingredient
Tirzepatide (a GLP1 and GIP receptor agonist)

How does it work?
By reducing your appetite

Dosage schedule
Increasing every 4 weeks to a maximum maintenance dose of 15mg

How often do you take it?
Once a week on the same day at the same time

How do you take it?
With an injectable pen that contains 4 prefilled doses

Effectiveness according to clinical studies
People lose up to 22.5% of their body weight after taking the maximum maintenance dose of 15mg after 72 weeks, according to the SURMOUNT-1 clinical trial

Very common side effects
nausea
diarrhoea
vomiting
constipation

Prescription only?
Yes